You are currently viewing our desktop site, do you want to visit our Mobile web app instead?

Aspen strikes deal with India’s Laurus

In a bid to cut the cost of HIV drugs.
Aspen partners with India-based Laurus Labs to help reduce the cost of HIV drugs. Image: Supplied

Aspen Pharmacare agreed to a partnership with India’s Laurus Labs  to boost the supply of active pharmaceutical ingredients that will help reduce the cost of HIV drugs.

The Durban-based company plans to license intellectual property rights owned by Laurus, executive Stavros Nicolaou said by phone on Friday. The Indian company will gain a trading entity in South Africa as part of the deal, he said.

The move will put Aspen in a better position to bid for government contracts as the country plans to scale up treatment to 6 million people, Nicolaou said. The deal was first reported by Business Day newspaper.

The shares rose 1.3% in early trade in Johannesburg.

© 2019 Bloomberg L.P.

Get access to Moneyweb's financial intelligence and support quality journalism for only
R63/month or R630/year.
Sign up here, cancel at any time.

COMMENTS   0

You must be signed in to comment.

SIGN IN SIGN UP

LATEST CURRENCIES  

USD / ZAR
GBP / ZAR
EUR / ZAR

Podcasts

NEWSLETTERS WEB APP SHOP PORTFOLIO TOOL TRENDING CPD HUB

Follow us:

Search Articles:Advanced Search
Click a Company: